Inventor · disambiguated record
Cheng Zhu
Also filed as: ZHU CHENG
25 granted patents·2 pending applications·189 citations·filing 1995–2022
94Inventor score
Files withMERCK SHARP & DOHME16BERGER RICHARD4MERCK SHARP & DOHME LLC2EDMONDSON SCOTT1EDMONDSON SCOTT D1
Top patents by PatentIndex Score
27 records- 0195US8247415B2Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Aug 21, 2012·40 cites·16 claims
- 0294US9227973B2Pyridine CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·16 cites·4 claims
- 0394US8399480B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Mar 19, 2013·36 cites·20 claims
- 0492US8354403B2Pyrrolidine derived beta 3 adrenergic receptor agonistsMERCK SHARP & DOHME·Filed 2010·Granted Jan 15, 2013·15 cites·14 claims
- 0591US8653260B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2012·Granted Feb 18, 2014·18 cites·11 claims
- 0690US9296750B2Spirolactam CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Mar 29, 2016·16 cites·3 claims
- 0790US9227972B2Aliphatic spirolactam CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·17 cites·4 claims
- 0885US9932311B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Apr 3, 2018·4 cites·24 claims
- 0975US7795265B2Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Sep 14, 2010·3 cites·16 claims
- 1067US9018224B2Substituted cyclopropyl compounds useful as GPR119 agonistsMERCK SHARP & DOHME·Filed 2012·Granted Apr 28, 2015·1 cites·25 claims
- 1165US12497403B2Factor XIa inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 16, 2025·0 cites·19 claims
- 1260US5929084AHuperzine A derivatives, their preparation and their useSHANGAHI INST MATERIA MEDICA·Filed 1995·Granted Jul 27, 1999·23 cites·9 claims
- 1353US12344616B2Factor XIa inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 1, 2025·0 cites·17 claims
- 1451US11162124B2Alcohol dehydrogenase mutant and application thereof in cofactor regenerationUNIV JIANGNAN·Filed 2020·Granted Nov 2, 2021·0 cites·9 claims
- 1551US8501786B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Aug 6, 2013·0 cites·8 claims
- 1649US2023133133A1Aldehyde generation via alkene hydroformylationUNIV NORTH CAROLINA STATE·Filed 2021·Application pending·0 cites
- 1746US10519115B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 31, 2019·0 cites·21 claims
- 1845US2015087641A1Heterocyclic cgrp receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 1943US7858629B2Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Dec 28, 2010·0 cites·17 claims
- 2043US7759352B2Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Jul 20, 2010·0 cites·16 claims
- 2142US10864211B2Hydroxy isoxazole compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2017·Granted Dec 15, 2020·0 cites·14 claims
- 2242US7977339B2Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2010·Granted Jul 12, 2011·0 cites·13 claims
- 2341US10143681B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 4, 2018·0 cites·16 claims
- 2438US10214512B2Factor XIA inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 26, 2019·0 cites·14 claims
- 2534US10000454B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·22 claims
- 2633US8604038B2Pyrrolidine derived beta 3 adrenergic receptor agonistsEDMONDSON SCOTT D·Filed 2010·Granted Dec 10, 2013·0 cites·14 claims
- 2732US8957062B2Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatmentEDMONDSON SCOTT·Filed 2012·Granted Feb 17, 2015·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Cheng Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →